The effects of cyclophosphamide, vinblastine and azathioprine on spleen and bone marrow hemopoietic stem cells (assayed as CFU-S, CFU-C and CFU-E) during an early phase of erythropoietic response to bleeding have been measured. Differences of effect seem to be mainly related to the number of progenitor cells present at the time of drug administration.